Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral hepatitis prophylaxis

F J Carrilho1, A V França, L C da Silva

  • 1Department of Gastroenterology, Medical School, University of São Paulo.

Revista Do Hospital Das Clinicas
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of Biomarkers of Atherogenic Risk in Liver Transplantation Recipients.

Transplantation proceedings·2018
Same author

Transient Elastography in Acute Cellular Rejection Following Liver Transplantation: Systematic Review.

Transplantation proceedings·2018
Same author

Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil.

Archives of virology·2017
Same author

Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis.

Journal of viral hepatitis·2015
Same author

Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2015

Viral hepatitis, including hepatitis A, B, C, D, and E, causes significant liver disease. This review covers prophylaxis and management strategies for these infections, emphasizing prevention.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Viral hepatitis is a primary cause of jaundice, acute liver failure, liver cirrhosis, and hepatocellular carcinoma.
  • The high morbidity and mortality associated with viral hepatitis necessitate effective prophylaxis and management.
  • Hepatitis A and B are common viral causes of liver inflammation with significant global health implications.

Purpose of the Study:

  • To review general measures for viral hepatitis prevention.
  • To discuss active and passive immunoprophylaxis strategies against hepatitis A, B, and Yellow Fever.
  • To outline the general management approaches for hepatitis C, D, and E virus infections.

Main Methods:

  • Literature review of existing studies and guidelines on viral hepatitis.

Related Experiment Videos

  • Synthesis of information on prophylactic measures, including vaccination and immunoglobulin therapy.
  • Compilation of current management strategies for different types of viral hepatitis.

    • Main Results:

    • General preventive measures are crucial for reducing viral hepatitis transmission.
    • Active and passive immunoprophylaxis are effective for hepatitis A and B.
    • Management of hepatitis C, D, and E focuses on supportive care and antiviral therapies where available.

    Conclusions:

    • Prophylaxis and timely management are essential to reduce the burden of viral hepatitis.
    • Immunoprophylaxis plays a key role in preventing hepatitis A and B.
    • Comprehensive strategies are needed for the control and treatment of all viral hepatitis types.